Aims and scope of journal
Modern Pathology is an international journal owned by The United States & Canadian Academy of Pathology (USCAP). Modern Pathology aims to provide an authoritative platform for publishing the highest quality clinical and translational research studies in pathology.
Original manuscripts are the main focus of Modern Pathology. Our scientific communication is enriched by high impact editorials, reviews, and practice guidelines that relate to all aspects of precision diagnostics in human pathology. As such, Modern Pathology’s scope encompasses advances in the molecular diagnostics and genomic classifications of disease as well as discoveries in immune-oncology, computational science and applied bioinformatics, and digital pathology.
The journal features the following types of papers:
- Original Articles
- Review Articles
- Long Course Articles
Submit your next manuscript to Modern Pathology and benefit from:
- One of the highest ranked pathology journals
- International and highly respected editorial team
- Rapid decision and publication times
- Wide exposure and article visibility via nature.com
- Owned by the United States and Canadian Academy of Pathology, the global leader in pathology education
- Engaged and growing Twitter following for Modern Pathology at @ModernPathology
- Easily track the status of your article during peer review using the Author Dashboard
- Share your article through SharedIt - Springer Nature’s content-sharing initiative allowing authors and subscribers to share links to view-only, full-text articles from this journal
Our publishing models
Modern Pathology is a Transformative Journal (TJ). When research is accepted for publication, authors can choose to publish using either the traditional publishing route OR via immediate gold Open Access.
Modern Pathology is actively committed to becoming a fully Open Access journal. We will increase the number of articles we publish OA, with the eventual goal of becoming a fully Open Access journal. A journal that commits to this process is known as a Transformative Journal.
Authors may need to take specific actions to achieve compliance with funder and institutional open access mandates. If your research is supported by a funder that requires immediate open access (e.g. according to Plan S principles) then you should select the gold OA route, and we will direct you to the compliant route where possible. For authors selecting the subscription publication route our standard licensing terms will need to be accepted including our self-archiving policies. Those standard licensing terms will supersede any other terms that the author or any third party may assert apply to any version of the manuscript.
Article-level metrics such as number of downloads, citations and online attention provide an overview of the attention received by a paper, and are available from each article page.
The 2020 peer review performance metrics for Modern Pathology are shown below:
Average time to decision without external review - 3 days
Average time to decision following external review - 26 days
Article page views - 1,754,035
The 2020 journal metrics* for Modern Pathology are as follows:
2-year Impact Factor*: 7.842
5-year Impact Factor*: 8.048
Immediacy index*: 2.901
Eigenfactor® score*: 0.02119
Article influence score*: 2.482
JCR Rank*: PATHOLOGY 6/77
Journal Citation Score*: 2.64
*2020 Journal Citation Reports® Science Edition (Clarivate Analytics, 2020)
For more information on these journal metrics, please visit this link
Current Contents (Clinical Medicine, Life Sciences, Science Citation Index, SciSearch and Research Alert)
ISSN and eISSN
The international standard serial number (ISSN) for Modern Pathology is 0893-3952 and the electronic international standard serial number (eISSN) is 1530-0285.
Modern Pathology now provides its latest table of contents as an RSS web feed. This allows users with an RSS reader to receive automatic updates whenever new content is added to these pages.
Find out more about RSS feeds, how to download an RSS reader and see all the news feeds offered by Springer Nature.